Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-25,000
Closed -$139K 766
2015
Q1
$139K Hold
25,000
﹤0.01% 686
2014
Q4
$181K Buy
+25,000
New +$168K ﹤0.01% 602

Other funds holding CDNA

UBS O'Connor's CDNA Position: Q2 2015 in Review

UBS O'Connor sold out of CareDx (CDNA) in Q2 2015, closing a stake of 25,000 shares — an estimated $139K sold.

UBS O'Connor first reported a position in CDNA in Q4 2014 and held it in 2 quarters. The position peaked at $181K in Q4 2014. 24 funds tracked by Wall St. Rank hold CDNA as of Q2 2015.

  • UBS O'Connor reported no remaining CareDx position as of Q2 2015 after selling out during the quarter.
  • UBS O'Connor sold 25,000 CareDx shares in Q2 2015, an estimated $139K.
  • UBS O'Connor first reported a position in CareDx in Q4 2014 and held it in 2 quarters.
  • UBS O'Connor's CareDx position peaked at $181K in Q4 2014.
  • 24 funds tracked by Wall St. Rank held CareDx as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.